MTAP and glioblastoma: In contrast, we found that ALA treatment has no effect on sphere formation capacity when performing the ELDA with an MTAP-wildtype (WT) patient-derived GBM cell line (Figure S1D), supporting the specific effect of this treatment on MTAP-deficient tumor cells.